China Traditional Chinese Medicine Holdings Files Director List to HKEX

Reuters
2025/11/26
<a href="https://laohu8.com/S/CHIZF">China Traditional Chinese Medicine</a> Holdings Files Director List to HKEX

China Traditional Chinese Medicine Holdings Co. Limited has filed an updated list of directors and their roles with the Hong Kong Stock Exchange (HKEX). The board consists of Executive Directors Mr. Yang Jun (Chairman), Mr. Li Hongjian, and Mr. Peng Li; Non-executive Directors Mr. Liu Haijian, Mr. Li Xiangrong, Mr. Zu Jing, Ms. Xu Jinghui, and Mr. Huang Hao; and Independent Non-executive Directors Mr. Xie Rong, Mr. Yu Tze Shan Hailson, Mr. Qin Ling, and Mr. Li Weidong. Committee memberships are as follows: Mr. Yang Jun serves as Chairman of both the Nomination Committee and the Strategic Committee, with Mr. Li Hongjian as a member of both, and Mr. Peng Li as a member of the Strategic Committee. Mr. Liu Haijian is a member of the Remuneration and Evaluation Committee, while Mr. Li Xiangrong is a member of the Strategic Committee. Mr. Zu Jing serves on the Audit Committee, and Ms. Xu Jinghui is on the Nomination Committee. Mr. Xie Rong chairs the Audit Committee and is a member of the Remuneration and Evaluation Committee and the Nomination Committee. Mr. Yu Tze Shan Hailson is a member of all four committees. Mr. Qin Ling chairs the Remuneration and Evaluation Committee and is a member of the Audit, Nomination, and Strategic Committees. Mr. Li Weidong is a member of all four committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Traditional Chinese Medicine Holdings Co. Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251126-11929251), on November 26, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10